Dr. Jan-Uwe Claas

Experience

• 

  InfectoPharm Arzneimittel und Consilium GmbH

  Mar 1995 - Nov 1996

  Scientific Productmanager Infectiology
• 

  The Janssen Pharmaceutical Companies of Johnson & Johnson

  Jan 1996 - Jan 2002

  Responsible for all marketing activities and marketing budget (> 10 Mio DM)2001 Risperdal sales above 100 Mio DM Responsible for Key opinion leader management and Investigator Initiated Studies in GermanyDevelopment of scientifc communication strategy later implemented across Europe

  • Productmanager Risperdal

    Jan 2000 - Jan 2002

  • Head of Medical Affairs Oncology

    Jan 1998 - Jan 1999

  • Medical Manager Oncology

    Jan 1996 - Jan 1997
• 

  Grünenthal Group

  Feb 2002 - Feb 2022

  General Manager responsible for the Country Cluster Europe Organization consisting of Portugal, Switzerland, Austria, Belgium, Luxembourg, Netherlands, Ireland, Sweden, Denmark, Norway and Finland. Full P&L responsibility. Key achievements after setting up the new organisational structure with 250 employees:Doubling the profit margin within 3 years, from 25 % in 2017 to 50 % in 2020. Key focus: Implement measures to improve team culture & quality of leadership and establish new governance structure & processes to foster cross-functional working. Meno dettagli 180 employees, full P&L responsibilityIncrease of UK Profit Margin from -23 % in 2011 to +38% in 2016 due to sales growth of innovations, focussed investment and improved quality of services. Establish Grϋnenthal UK as the key player in the pain market by introducing innovative customer services. Key focus: Close cooperation & alignment of all departments/teams, up-skilling of customer facing teams & improvement of market access.Appointed member of the ABPI (Association of the British Pharmaceutical Industry) Board of Directors. Grünenthal Best Performance Award 2013 for UK turnaround. Meno dettagli

  • General Manager Country Cluster Europe

    Jan 2017 - Feb 2022

  • Head Marketing Europe (Senior Vice President)

    Jan 2017 - Jan 2017

  • General Manager United Kingdom & Ireland

    Jan 2011 - Jan 2017

  • Senior Vice President Marketing Europe & Australia

    Jan 2010 - Jan 2011

  • Vice President Global Marketing

    Jan 2009 - Jan 2010

  • Head of Global Marketing Narcotic Analgesics

    Nov 2007 - Apr 2009

  • Global Commercial Lead New Analgesics

    Jan 2004 - Jan 2007

  • Head of Marketing Germany

    Feb 2002 - Jan 2004
• 

  XPLORE by UnternehmerTUM

  Jan 2022 - now

  Expert Coach Healthcare & Mentor Entrepreneurship Program GeneNovate and XPLORE (UnternehmerTUM)

  UnternehmerTUM’s pre-Incubation Program XPLORE supports founders with tech-based start-up project to prepare you for incubation and the acquisition of pre-seed capitalGeneNovate: Empowering Innovators and Entrepreneurs in Gene and Cell Therapies

• 

  Dr. Claas Consulting GmbH

  Feb 2022 - now

  Founder

  Dr. Claas Consulting supports Start-Up enterprises intending to set up new commercial business in European countries as well as companies with already established business, that intends to launch or re-launch brands in Europe. The support can be…- Project-based with a focus on strategy and/or operative implementation- Interim-Management based (CEO, CCO, GM)The specific benefits of Dr. Claas Consulting are the…- Broad range from strategy to implementation- Focus on optimized & targeted investment- Implementation oriented approach based on in-depth practical experience- 360-degree view across all functions Meno dettagli

• 

  Healthcare Shapers

  Mar 2022 - now

  Partner

  Each partner in the network has outstanding skills and has qualified in an intensive selection process to become a member. Practical experience is our strength. The partners of Healthcare Shapers are consultants with many years of practical experience in the healthcare industry. Our diversity promotes unconventional ideas, creating new insights and approaches.

• 

  Neuraxpharm

  Jan 2023 - Jan 2024

  Interim Head of Marketing

  Support the private equity funded international pharmaceutical company NEURAXPHARM in the transformation from generic business to provider of innovative brands.Successful launch of the new Anti-CD20 Antibody BRIUMVI for Multiple Sclerosis in the highly competitive German MS market.

• 

  Hands On L&D

  Apr 2023 - now

  Senior Consultant & Lead Facilitator

  As a senior consultant and lead facilitator, I lead a variety of learning programs like Healthcare Economics, Market Access, Healthcare Compliance, GxP & Drug Development that help advance capabilities from early on in career through executive leadership with a focus on the Health Care Industry. Based on my 30 years of experience in Health Care & Pharma I support professionals especially in the US Biotech industry to further develop their capabilities and skill-sets.

• 

  Startup in stealth mode

  Jan 2024 - now

  Business Angel

  Startup in stealth mode (Biotechnology)

• 

  Kora Healthcare

  Jan 2024 - now

  Special Advisor to the Board of Directors

  Kora Healthcare is a fully integrated healthcare company with core competencies across Research, Development & Innovation, Scientific & Medical Affairs, Regulatory Affairs & Pharmacovigilance, Quality, Supply Chain, Marketing & Sales, Finance and Customer Services.

• 

  PROVIREX Genome Editing Therapies GmbH

  Mar 2025 - now

  Chief Executive Officer